Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 18 2013
Print RSS Feed

Breaking News

Related Searches:
PharmaNet Development Group

August 24, 2007
Bengt Danielsson, M.D., Ph.D., has been appointed vice president, PharmaNet Consulting. He joins the company from the Swedish Medical Product Agency where he served as scientific director/professor in pharmacology and toxicology for the past three ye…  Read More »
Pro-Pharmaceuticals Selects Camargo for Regulatory Support

August 23, 2007
Pro-Pharmaceuticals, Inc. has retained Camargo Pharmaceutical Services to provide strategic regulatory support for the company’s 505(b)(2) submissions for Davanat with the FDA. Camargo’s regulatory support includes the preparation and sub…  Read More »
Cephalon To Acquire Amrix from ECR

August 23, 2007
Cephalon, Inc. has signed an agreement to acquire the North American rights to Amrix (cyclobenzaprine hydrochloride extended-release capsules) from ECR Pharmaceuticals for $100 million cash. ECR is eligible to receive future cash payments based on th…  Read More »
GPC Biotech Restructures

August 23, 2007
GPC Biotech AG is restructuring and will reduce its U.S. staff by 46 employees (approximately 15%) with reductions in the commercialization, drug development and general and administrative groups. The company also announced that Martine George, M.D.…  Read More »
Pfizer

August 22, 2007
Frank A. D'Amelio has been named senior vice president and chief financial officer of Pfizer, effective in mid-September. Mr. D'Amelio is a senior executive with almost three decades of operating and financial experience at AT&T, Lucent Technolog…  Read More »
Pfizer Breaks Ground at Chesterfield

August 22, 2007
Pfizer broke ground on a $50 million expansion at its Chesterfield campus that reflects the company's increased investment in biopharmaceuticals. The expansion doubles the size of a pilot plant that produces protein-based, injectable biologic drugs f…  Read More »
Quintiles

August 22, 2007
Hugo Stephenson, M.D. has been appointed president of iGuard, for Quintiles Transnational Corp., effective immediately. Dr. Stephenson will lead the company's new service that offers personalized safety information and alerts to patients taking presc…  Read More »
FDA Approves ImClone's Manufacturing Facility

August 21, 2007
ImClone Systems, Inc. received approval from the FDA for a second facility to manufacture Erbitux. This new 250,000-sq.-ft. multi-suite manufacturing facility, referred to as "BB50", more than doubles the company's total production capacity…  Read More »
MPI Research

August 21, 2007
MPI Research has appointed David Serota, Ph.D., DABT to the position of vice president, toxicology and pathology, as well as a member of the company's senior management team, and Tina Rogers, Ph.D., DABT joined the company as the associate director o…  Read More »
Abraxis, TRSI Enter Licensing/Development Pact

August 21, 2007
Abraxis BioScience, Inc. and The Scripps Research Institute (TRSI) have entered an exclusive licensing agreement for the worldwide development and commercialization of an epothilone therapeutic for the treatment of cancer. Epothilones are a new class…  Read More »
Enzon Sells Portion of PEG-INTRON Royalty

August 20, 2007
Enzon Pharmaceuticals, Inc. is selling 25% interest in its royalty from PEG-INTRON, marketed by Schering-Plough Corp. for $92.5 million to Drug Royalty Corp., Inc. (DRC). Enzon is also eligible to receive an additional one-time milestone payment of $…  Read More »
Alphora Expands Facilities for New Pilot Plant

August 20, 2007
Alphora Research, Inc. has invested in a new pilot plant facility in an effort to increase its range of services. The company recently expanded to include a 14,000-sq.-ft. facility. The cGMP pilot plant is currently under construction and is expected…  Read More »
Nexgen Acquires Manufacturing Facility

August 17, 2007
Nexgen Pharma, Inc. has acquired certain assets of The Chemins Company, Inc. located in Colorado Springs, CO. The acquisition includes 250,000 sq. ft. of manufacturing, laboratory and warehouse/distribution space. Gary Korngold, Nexgen's execut…  Read More »
ARTEC, Inc.

August 17, 2007
ARTEC, Inc. has made key appointments with the goal of initiating the production and global distribution of Tubercin and related immunostimulant medicines. "R&D of Tubercin is complete, requiring no further refinement or alteration in t…  Read More »
UCB Submits MAA for Vimpat

August 17, 2007
Schwarz Pharma, a subsidiary of UCB, submitted a MAA to the EMEA for Vimpat to treat diabetic neuropathic pain and it has been accepted for review. Vimpat is an anticonvulsant drug with a novel dual mode of action acting on CRMP-2 (collapsing…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: